Recent Perioperative Pharmacological Prevention of Acute Kidney Injury after Cardiac Surgery: A Narrative Review

Am J Cardiovasc Drugs. 2017 Feb;17(1):17-25. doi: 10.1007/s40256-016-0194-z.

Abstract

Acute kidney injury (AKI) is a common and severe complication of cardiac surgery, and related rates of both hospitalization and long-term mortality are increasing. A number of studies have explored the preventive effects of perioperative pharmacological therapy on AKI after cardiac surgery. However, the mechanisms of AKI are multifaceted, and no universal treatment has been confirmed as beneficial. We review and analyze several current perioperative pharmacological therapies for AKI after cardiac surgery to identify promising preventive strategies.

Publication types

  • Review

MeSH terms

  • Acute Kidney Injury / etiology
  • Acute Kidney Injury / metabolism
  • Acute Kidney Injury / prevention & control*
  • Cardiac Surgical Procedures / adverse effects*
  • Dexmedetomidine / therapeutic use
  • Humans
  • Hydrazones / therapeutic use
  • Perioperative Care / methods*
  • Postoperative Complications / etiology
  • Postoperative Complications / metabolism
  • Postoperative Complications / prevention & control*
  • Pyridazines / therapeutic use
  • Risk Factors
  • Simendan

Substances

  • Hydrazones
  • Pyridazines
  • Simendan
  • Dexmedetomidine